Dataset Information


Molecular and immunological characterization of a DNA-launched yellow fever virus 17D infectious clone.

ABSTRACT: Yellow fever virus (YFV)-17D is an empirically developed, highly effective live-attenuated vaccine that has been administered to human beings for almost a century. YFV-17D has stood as a paradigm for a successful viral vaccine, and has been exploited as a potential virus vector for the development of recombinant vaccines against other diseases. In this study, a DNA-launched YFV-17D construct (pBeloBAC-FLYF) was explored as a new modality to the standard vaccine to combine the commendable features of both DNA vaccine and live-attenuated viral vaccine. The DNA-launched YFV-17D construct was characterized extensively both in cell culture and in mice. High titres of YFV-17D were generated upon transfection of the DNA into cells, whereas a mutant with deletion in the capsid-coding region (pBeloBAC-YF/?C) was restricted to a single round of infection, with no release of progeny virus. Homologous prime-boost immunization of AAD mice with both pBeloBAC-FLYF and pBeloBAC-YF/?C elicited specific dose-dependent cellular immune response against YFV-17D. Vaccination of A129 mice with pBeloBAC-FLYF resulted in the induction of YFV-specific neutralizing antibodies in all vaccinated subjects. These promising results underlined the potential of the DNA-launched YFV both as an alternative to standard YFV-17D vaccination and as a vaccine platform for the development of DNA-based recombinant YFV vaccines.

PROVIDER: S-EPMC4811652 | BioStudies |

REPOSITORIES: biostudies

Similar Datasets

| S-EPMC6896426 | BioStudies
2009-01-01 | S-EPMC2749449 | BioStudies
| S-EPMC6123396 | BioStudies
| S-EPMC7697718 | BioStudies
| S-EPMC6082969 | BioStudies
| S-EPMC3323739 | BioStudies
| S-EPMC8076279 | BioStudies
2011-01-01 | S-EPMC3170363 | BioStudies
| S-EPMC6805994 | BioStudies
| S-EPMC7564786 | BioStudies